The shoes would monitor wearers’ movement, weight and falls, people familiar with the project told the publication. Verily has reportedly shown potential partners a prototype of the shoe, but it’s unclear whether the project is still active.
Health-tracking shoes could be used to identify sudden weight gain — a change that’s sometimes indicative of water retention, a symptom of congestive heart failure, CNBC suggests.
Verily did not respond to CNBC’s request for comment. Other projects Verily is working on include a stabilizing spoon, a smartwatch for clinical research and “smart” contact lenses.
More articles on health IT:
Epic’s MyChart earns ‘Best in KLAS’ for patient portals
Athenahealth adds HIPAA risk analysis tool to EHR app store
2 ways Apple is promoting heart month in February
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.